Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development
Otávio Melo Espíndola, Carlos Otávio Brandão, Yago Côrtes Pinheiro Gomes, Marilda Siqueira, Cristiane Nascimento Soares, Marco Antônio Sales Dantas Lima, Ana Claudia Celestino Bezerra Leite, Guilherme Torezani, Abelardo Queiroz Campos Araujo, Marcus Tulius Teixeira Silva, Otávio Melo Espíndola, Carlos Otávio Brandão, Yago Côrtes Pinheiro Gomes, Marilda Siqueira, Cristiane Nascimento Soares, Marco Antônio Sales Dantas Lima, Ana Claudia Celestino Bezerra Leite, Guilherme Torezani, Abelardo Queiroz Campos Araujo, Marcus Tulius Teixeira Silva
Abstract
Objectives: To analyze the cerebrospinal fluid (CSF) of patients with SARS-CoV-2 infection and neurological manifestations to provide evidence for the understanding of mechanisms associated with central nervous system (CNS) involvement in COVID-19.
Methods: Patients (n = 58) were grouped according to their main neurological presentation: headache (n = 14); encephalopathy (n = 24); inflammatory neurological diseases, including meningoencephalitis (n = 4), acute myelitis (n = 3), meningitis (n = 2), acute disseminated encephalomyelitis (ADEM) (n = 2), encephalitis (n = 2), and neuromyelitis optica (n = 1); and Guillain-Barré syndrome (n = 6). Data regarding age, sex, cerebrovascular disease, and intracranial pressure were evaluated in combination with CSF profiles defined by cell counts, total protein and glucose levels, concentration of total Tau and neurofilament light chain (NfL) proteins, oligoclonal band patterns, and detection of SARS-CoV-2 RNA.
Results: CSF of patients with inflammatory neurological diseases was characterized by pleocytosis and elevated total protein and NfL levels. Patients with encephalopathy were mostly older men (mean age of 61.0 ± 17.6 years) with evidence of cerebrovascular disease. SARS-CoV-2 RNA in CSF was detected in 2 of 58 cases: a patient with refractory headache, and another patient who developed ADEM four days after onset of COVID-19 symptoms. Three patients presented intrathecal IgG synthesis, and four had identical oligoclonal bands in CSF and serum, indicating systemic inflammation.
Conclusion: Patients with neurological manifestations associated with COVID-19 had diverse CSF profiles, even within the same clinical condition. Our findings indicate a possible contribution of viral replication on triggering CNS infiltration by immune cells and the subsequent inflammation promoting neuronal injury.
Keywords: COVID-19; Cerebrospinal fluid; Neurofilament light protein; Oligoclonal bands; SARS-CoV-2; Total Tau protein.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Figures
References
- Abdi S., Ghorbani A., Fatehi F. The association of SARS-CoV-2 infection and acute disseminated encephalomyelitis without prominent clinical pulmonary symptoms. J Neurol Sci. 2020;416(June):117001.
- Alberti P., Beretta S., Piatti M., Karantzoulis A., Piatti M.L., Santoro P. Guillain-Barré syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(4)
- Andersson M., Alvarez-Cermeño J., Bernardi G., Cogato I., Fredman P., Frederiksen J. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry. 1994;57(August (8)):897–902.
- Araujo A.Q.C., Silva M.T.T., Araujo A.P.Q.C. Zika virus-associated neurological disorders: a review. Brain. 2016;139(August (Pt 8)):2122–2130.
- Arbour N., Day R., Newcombe J., Talbot P.J. Neuroinvasion by human respiratory coronaviruses. J Virol. 2000;74(October (19)):8913–8921.
- Bernard-Valnet R., Pizzarotti B., Anichini A., Demars Y., Russo E., Schmidhauser M. Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection. Eur J Neurol. 2020;(May)
- Bookstaver P.B., Mohorn P.L., Shah A., Tesh L.D., Quidley A.M., Kothari R. Management of viral central nervous system infections: a primer for clinicians. J Cent Nerv Syst Dis. 2017;9 1179573517703342.
- Brasil P., Sequeira P.C., Freitas A.D., Zogbi H.E., Calvet G.A., de Souza R.V. Guillain-Barré syndrome associated with Zika virus infection. Lancet. 2016;387(April (10026)):1482.
- Chen R., Wang K., Yu J., Howard D., French L., Chen Z. The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain [Internet] Neuroscience. 2020;(April) Available from:
- Ciaccio M., Agnello L. Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19) Diagnosis (Berl) 2020;(June)
- Coen M., Jeanson G., Culebras Almeida L.A., Hübers A., Stierlin F., Najjar I. Guillain-Barré syndrome as a complication of SARS-CoV-2 infection. Brain Behav Immun. 2020;87:111–112.
- Demirci Otluoglu G., Yener U., Demir M.K., Yilmaz B. Encephalomyelitis associated with Covid-19 infection: case report. Br J Neurosurg. 2020;(July):1–3.
- Desforges M., Le Coupanec A., Stodola J.K., Meessen-Pinard M., Talbot P.J. Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis. Virus Res. 2014;194(December):145–158.
- Desforges M., Le Coupanec A., Dubeau P., Bourgouin A., Lajoie L., Dubé M. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2019;12(1)
- Dogan L., Kaya D., Sarikaya T., Zengin R., Dincer A., Akinci I.O. Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: case series. Brain Behav Immun. 2020;87:155–158.
- Dong E., Du H., Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–534.
- Dubé M., Le Coupanec A., Wong A.H.M., Rini J.M., Desforges M., Talbot P.J. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol. 2018;92(17)
- Ellul M.A., Benjamin L., Singh B., Lant S., Michael B.D., Easton A. Neurological associations of COVID-19. Lancet Neurol. 2020;(July) S1474442220302210.
- Espíndola O de M., Siqueira M., Soares C.N., Lima M.A.S.D de, Leite A.C.C.B., Araujo A.Q.C. Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid. Int J Infect Dis. 2020;96(July):567–569.
- Garg R.K., Paliwal V.K., Gupta A. Encephalopathy in patients with COVID-19: a review. J Med Virol. 2020;(June)
- Gray M.P., Gorelick M.H. Acute disseminated encephalomyelitis. Pediatr Emerg Care. 2016;32(June (6)):395–400.
- Gris J.-C., Perez-Martin A., Quéré I., Sotto A. COVID-19 associated coagulopathy: the crowning glory of thrombo-inflammation concept. Anaesth Crit Care Pain Med. 2020;39(3):381–382.
- Haertle M., Kallweit U., Weller M., Linnebank M. The presence of oligoclonal IgG bands in human CSF during the course of neurological diseases. J Neurol. 2014;261(March (3)):554–560.
- Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268–2270.
- Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
- Jacob A., Weinshenker B.G. An approach to the diagnosis of acute transverse myelitis. Semin Neurol. 2008;28(February (1)):105–120.
- Juliao Caamaño D.S., Alonso Beato R. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2. J Clin Neurosci. 2020;77(July):230–232.
- Khalil M., Teunissen C.E., Otto M., Piehl F., Sormani M.P., Gattringer T. Neurofilaments as biomarkers in neurological disorders. Nature Rev Neurol. 2018;14(October (10)):577–589.
- Kim J.E., Heo J.H., Kim H.O., Song S.H., Park S.S., Park T.H. Neurological complications during treatment of middle east respiratory syndrome. J Clin Neurol. 2017;13(July (3)):227–233.
- Li Y., Li M., Wang M., Zhou Y., Chang J., Xian Y. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol. 2020;(July)
- Mao L., Jin H., Wang M., Hu Y., Chen S., He Q. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;(April)
- Mehta N.S., Mytton O.T., Mullins E.W.S., Fowler T.A., Falconer C.L., Murphy O.B. SARS-CoV-2 (COVID-19): what do we know about children? A systematic review. Clin Infect Dis. 2020;(May)
- Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034.
- Moriguchi T., Harii N., Goto J., Harada D., Sugawara H., Takamino J. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94(May):55–58.
- Ottaviani D., Boso F., Tranquillini E., Gapeni I., Pedrotti G., Cozzio S. Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci. 2020;41(June (6)):1351–1354.
- Oxley T.J., Mocco J., Majidi S., Kellner C.P., Shoirah H., Singh I.P. Large-Vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382(20):e60.
- Parsons T., Banks S., Bae C., Gelber J., Alahmadi H., Tichauer M. COVID-19-associated acute disseminated encephalomyelitis (ADEM) J Neurol. 2020;267(October (10)):2799–2802.
- Pilotto A., Odolini S., Masciocchi S., Comelli A., Volonghi I., Gazzina S. Steroid-Responsive encephalitis in coronavirus disease 2019. Ann Neurol. 2020;(May)
- Poyiadji N., Shahin G., Noujaim D., Stone M., Patel S., Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology. 2020;296(2):E119–E120.
- Puelles V.G., Lütgehetmann M., Lindenmeyer M.T., Sperhake J.P., Wong M.N., Allweiss L. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383(August (6)):590–592.
- Rajapakse N., Dixit D. Human and novel coronavirus infections in children: a review. Paediatr Int Child Health. 2020;(June):1–20.
- Scolding N. The differential diagnosis of multiple sclerosis. J Neurol Neurosurg Psychiatry. 2001;71 Suppl 2(December) ii9-15.
- Sharma K., Tengsupakul S., Sanchez O., Phaltas R., Maertens P. Guillain-Barré syndrome with unilateral peripheral facial and bulbar palsy in a child: a case report. SAGE Open Med Case Rep. 2019;7 2050313X19838750.
- Sloots T.P., Whiley D.M., Lambert S.B., Nissen M.D. Emerging respiratory agents: new viruses for old diseases? J Clin Virol. 2008;42(July (3)):233–243.
- Tenembaum S., Chitnis T., Ness J., Hahn J.S., International Pediatric MS Study Group Acute disseminated encephalomyelitis. Neurology. 2007;68(April (16 Suppl 2)):S23–S36.
- Toscano G., Palmerini F., Ravaglia S., Ruiz L., Invernizzi P., Cuzzoni M.G. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574–2576.
- Trojanowski J.Q., Schuck T., Schmidt M.L., Lee V.M. Distribution of tau proteins in the normal human central and peripheral nervous system. J Histochem Cytochem. 1989;37(February (2)):209–215.
- Wakerley B.R., Yuki N. Infectious and noninfectious triggers in Guillain-Barré syndrome. Expert Rev Clin Immunol. 2013;9(July (7)):627–639.
- Ye M., Ren Y., Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun. 2020;(April) S0889159120304657.
- Zanin L., Saraceno G., Panciani P.P., Renisi G., Signorini L., Migliorati K. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir (Wien) 2020;162(July (7)):1491–1494.
- Zhang A.J., Lee A.C.-Y., Chu H., Chan J.F.-W., Fan Z., Li C. SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters. Clin Infect Dis. 2020;(July)
- Zhang B.-Z., Chu H., Han S., Shu H., Deng J., Hu Y.-F. SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res. 2020;30(10):928–931.
- Zhao H., Shen D., Zhou H., Liu J., Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383–384.
- Zubair A.S., McAlpine L.S., Gardin T., Farhadian S., Kuruvilla D.E., Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;(May)
Source: PubMed